Home > Boards > US Listed > Biotechs > Minerva Neurosciences, Inc. (NERV)

NERV bullish 11.20

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 457
Posts 9,985
Boards Moderated 1
Alias Born 04/28/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2020 4:28:21 PM
A POTENTIALLY NOVEL MECHANISM TO TREAT THE NEGATIVE... GlobeNewswire Inc. - 3/24/2020 8:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/13/2020 6:01:06 AM
MINERVA NEUROSCIENCES UPDATES MARKET ON SHARE PRICE DROP AND TRADING HALT GlobeNewswire Inc. - 3/12/2020 3:15:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/9/2020 8:53:39 AM
Minerva Neurosciences Reports Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates GlobeNewswire Inc. - 3/9/2020 7:30:10 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/9/2020 6:33:20 AM
Minerva Neurosciences to Report Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates on March 9, 20... GlobeNewswire Inc. - 3/2/2020 8:30:10 AM
Minerva Neurosciences to Host Key Opinion Leader Meeting on Avolition, the Most Central Domain for the Successful Treatment o... GlobeNewswire Inc. - 2/28/2020 8:30:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 1:52:54 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 5:23:21 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/7/2020 11:26:46 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2020 12:21:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/5/2020 8:30:50 AM
Minerva Neurosciences Announces Completion of Patient Enrollment in Phase 3 Trial of Roluperidone for the Treatment of Negati... GlobeNewswire Inc. - 2/5/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/6/2020 4:50:03 PM
Minerva Neurosciences Announces Completion of Patient Screening in Phase 3 Trial of Roluperidone for the Treatment of Negativ... GlobeNewswire Inc. - 1/6/2020 8:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:54:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:54:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:53:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:52:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:51:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:49:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:49:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/3/2020 4:47:43 PM
stocktrademan   Monday, 08/01/16 09:45:03 AM
Re: None
Post # of 129 
NERV bullish 11.20






Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist